Skip to main content

Table 2 Laboratory data after 13 courses of hepatic arterial infusion chemotherapy

From: Advanced hepatocellular carcinoma with hepatic vein tumor thrombosis and renal dysfunction after hepatic arterial infusion chemotherapy effectively treated by liver resection with active veno-venous bypass: report of a case

Complete blood count

  

Tumor markers

WBC

5,100/μL

ChE

307 IU/L

AFP

13 ng/mL

RBC

323 ×104/μL

LDH

191 IU/L

PIVKA-II

15 mAU/mL

Hb

10.3 g/dL

T-Chol

245 mg/dL

  

Hct

30.5 %

TP

7.0 g/dL

Dye clearance test

Plt

14.6 ×104/μL

Alb

4.5 g/dL

ICG-R 15

9.7 %

  

Na

140 mEq/L

  

Coagulation tests

K

5.4 mEq/L

CT volumetry

PT-INR

1.11

Cl

106 mEq/L

Whole liver

1082 ml

APTT

28.0 sec

Ca

9.8 mg/dL

Right lobe

297 ml (27.4 %)

Blood chemistry

UA

8.6 mg/dL

Left lobe

785 ml (72.6 %)

AST

19 IU/L

UN

34.9 mg/dL

  

ALT

14 IU/L

Cr

1.93 mg/dL

  

ALP

231 IU/L

CRP

0.28 mg/dL

  

γGTP

21 IU/L

HbA1c

5.8 %

  

T.Bil

0.6 mg/dL

eGFR

27.1 mL/min/1.73 m2

  
  1. AFP alpha-fetoprotein, Alb albumin, ALT alanine aminotransferase, ALP alkaline phosphatase, APTT activated partial thromboplastin time, AST aspartate aminotransferase, ChE cholinesterase, CRP C-reactive protein, eGFR estimated glomerular filtration rate, γGTP gamma glutamyl transpeptidase, HBV hepatitis B virus, Hb hemoglobin, HbA1c hemoglobin A1c, Hct hematocrit, HCV hepatitis C virus, ICG-R 15 indocyanine green dye retention rate at 15 min, LDH lactate dehydrogenase, Plt platelets, PT-INR prothrombin time-international normalized ratio, RBC red blood cells, T.Bil total bilirubin, T.Chol total cholesterol, PIVKA-II protein induced by vitamin K absence or antagonist, TP total protein, UA uric acid, UN urea nitrogen, WBC white blood cells